Position in DXCM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$359,177
+$98,557 QoQ
Shares Held
5,333
+28.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#630
of 966 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Kera Capital Partners, Inc. holds $4,649,326 across 9 Medical Devices names. DXCM ranks #6 (7.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
10,392 | $942,970 | |
| 2 | EW |
Edwards Lifesciences Corp
|
9,774 | $884,156 | |
| 3 | PODD |
Insulet Corp
|
4,099 | $624,072 | |
| 4 | GMED |
Globus Medical Inc
|
6,250 | $493,812 | |
| 5 | MDT |
Medtronic plc
|
5,937 | $464,451 | |
| 6 | DXCM |
Dexcom Inc
This page
|
5,333 | $359,177 | |
| 7 | NVCR |
NovoCure Ltd
|
20,504 | $310,635 | |
| 8 | STE |
STERIS plc
|
1,459 | $307,221 |
All Filings in DXCM
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $359,177 | 5,333 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $260,620 | 4,150 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $267,338 | 4,028 | Shares | Sole | 2026-02-23 | |
| No filing history on record for this holder in this stock. | ||||||